Add Company
Join Now

Ascletis Revenue and Competitors

License our Company Data API

杭州市,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Ascletis's estimated annual revenue is currently $9M per year.(i)
  • Ascletis's estimated revenue per employee is $201,000

Employee Data

  • Ascletis has 45 Employees.(i)
  • Ascletis grew their employee count by 13% last year.

Ascletis's People

NameTitleEmail/Phone
1
VP OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$53.7M26716%N/AN/A
#2
$53.1M26421%N/AN/A
#3
$69.1M34426%N/AN/A
#4
$22.1M110-10%N/AN/A
#5
$63.9M31813%N/AN/A
#6
$29.9M14913%N/AN/A
#7
$1.7M17-6%$114.3MN/A
#8
$6.8M34-6%N/AN/A
#9
$12.5M62-9%N/AN/A
#10
$7.6M41-13%$123.9MN/A
Add Company

What Is Ascletis?

歌礼生物科技(杭州)有限公司

keywords:N/A

N/A

Total Funding

45

Number of Employees

$9M

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ascletis News

2022-04-17 - Ascletis Announces 3CLpro Inhibitor ASC11 Demonstrated ...

HANGZHOU, China and SHAOXING, China, April 19, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that its oral small...

2022-04-17 - Ascletis' oral drug shows potential for Covid-19 treatment

Ascletis Pharma has reported that its oral small molecule drug candidate ASC11 showed potential for the treatment of Covid-19.

2022-04-13 - Ascletis Announces Cooperation with China Meheco ...

for distribution of its ritonavir tablets in Chinese mainland. Ascletis Pharmaceuticals is a wholly-owned subsidiary of Ascletis, and China...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.6M480%N/A
#2
$14.3M5310%N/A
#3
$15.1M625%N/A
#4
$12.6M8113%N/A
#5
$26.1M1042%N/A